Pulmonx Corporation stock is up 28.68% since 30 days ago. The next earnings date is Feb 21, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 75% of the previous 3 December’s closed higher than November.
Pulmonx Corporation provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. The company also provides StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service. It serves emphysema patients in the United States, Europe, the Middle East, Africa, Asia-Pacific and internationally.